Editas Medicine, Inc. ( EDIT) - Stock Earnings
EDIT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
EDIT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.6 million USD | 24.7 million USD |
| 2026Q1 | -25.0 million USD | 2.8 million USD |
| 2026Q2 | -18.2 million USD | 11.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EDIT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.2 million USD | 78.1 million USD |
| 2024 | -237.1 million USD | 32.3 million USD |
| 2025 | -160.1 million USD | 40.5 million USD |
| 2026 Est. | — | — |
EDIT
Price: $2.35
Earnings Per Share: -0.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.6 million
Ebitda: -26.1 millionMarket Capitalization: 429.7 million